Navigation Links
First Controlled Large-Scale Intervention Angiotensin Receptor,Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study,Demonstrates Significant Reduction in Blood Pressure and Protection,of Organs with Valsartan

Unprecedented Evidence for the Effectiveness of Hypertension Treatment Valsartan in Preventing Cardiovascular Events in Japanese Patients

TOKYO, April 26, 2007 /Xinhua-PRNewswire/ -- The clinical outcomes of the JIKEI HEART Study, the large-scale clinical trial headed by the Jikei University School of Medicine, was today published in the internationally renowned medical journal The Lancet. The study, involving more than 3,000 patients, is one of the largest cardiovascular intervention trials conducted in a Japanese population under realistic clinical settings. It also is the first large- scale study evaluating the benefits of the ARB, valsartan, in Japanese patients.

In the study, valsartan was added to conventional therapy to control blood pressure and protect against cardiovascular events and stroke. The results showed significant benefit with the use of valsartan, including a 39% decrease in cardiovascular events and a 40% decrease in stroke compared to conventional non-ARB therapy. Initiated in 2001, the JIKEI HEART Study was terminated earlier than anticipated at the request of the Data and Safety Monitoring Board due to superior outcomes for the valsartan group over the control group.

"Treatment of hypertension needs to account for blood pressure control but also should take into account the prevention of cardiovascular diseases over an extended period," said Seibu Mochizuki, M.D., PhD, formerly of Jikei University School of Medicine, chief investigator of the JIKEI HEART Study. "In the JIKEI HEART Study we accomplished both -- we achieved the lowest blood pressure value ever set in a morbidity/mortality outcomes trial and saw tremendous benefit for the valsartan arm in reducing the risk of cardiovascular events as well as stroke. Because of this, valsartan will play an important role in treating hypertension as it has been shown to lower blood pressure while being highly protective of end o
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
(Date:9/2/2014)...  Numotion is pleased to announce the appointment of ... Mark is a 30-year retired veteran of GE ... organization and was a GE Company Officer since 1999 and ... years running business units within GE Healthcare, with the most ... "We are delighted to welcome Mark to our ...
(Date:9/2/2014)... NEW YORK , Sept. 2, 2014 ... available in its catalogue: Asia - ... http://www.reportlinker.com/p02353212/Asia---Pacific-Minimally-Invasive-Surgery-Spinal-Device-Market.html The growth rate ... MIS spinal device market will remain at double-digit levels ... spinal surgeries as the future of this field. The ...
(Date:9/2/2014)... Sept. 2, 2014 Depomed, Inc. (Nasdaq: ... offer, subject to market and other conditions, $230 million ... (the "Notes"). Depomed, Inc. ("Depomed") expects to grant the ... up to an additional $34.5 million aggregate principal amount ... RBC Capital Markets, LLC will act as joint book-running ...
Breaking Medicine Technology:Asia - Pacific Minimally Invasive Surgery Spinal Device Market 2Asia - Pacific Minimally Invasive Surgery Spinal Device Market 3Asia - Pacific Minimally Invasive Surgery Spinal Device Market 4Asia - Pacific Minimally Invasive Surgery Spinal Device Market 5Asia - Pacific Minimally Invasive Surgery Spinal Device Market 6Asia - Pacific Minimally Invasive Surgery Spinal Device Market 7Asia - Pacific Minimally Invasive Surgery Spinal Device Market 8Asia - Pacific Minimally Invasive Surgery Spinal Device Market 9Asia - Pacific Minimally Invasive Surgery Spinal Device Market 10Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 2Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 3
... Decision Resources, one of the world,s leading research ... that biosimilar insulins and insulin analogues stand to erode ... Europe (France, Germany, Italy, Spain and U.K.) by 2018, ... , As insulins are relatively easy to develop and ...
... Corporation (Nasdaq: SMTS ) today announced that it ... Partners II, LLC ("Raba coreFoundry"). Under terms of ... specified rights of the U.S. Government and rights retained ... technology developed at The Johns Hopkins University. Integration ...
Cached Medicine Technology:Biosimilar Insulins and Insulin Analogues Stand to Erode $6.1 Billion in Brand Sales in the U.S. and Europe by 2018 2Biosimilar Insulins and Insulin Analogues Stand to Erode $6.1 Billion in Brand Sales in the U.S. and Europe by 2018 3Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 2Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 3Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 4Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 5
(Date:9/2/2014)... Fla. (PRWEB) September 02, 2014 ... join together in Tampa Bay from September 4-6 ... annual Scientific Symposium and FARA Energy Ball Gala. ... USF Ataxia Research Center in their pursuit of ... affected by the progressive neuromuscular disease Friedreich’s ataxia ...
(Date:9/2/2014)... Los Angeles, CA (PRWEB) September 03, 2014 ... helps health enthusiasts, bodybuilders, and athletes obtain the ... announced its launch. The site, which focuses mainly ... is dedicated to helping individuals increase their workout ... to an article available on Top Creatine Monohydrate, ...
(Date:9/2/2014)... UWDress.com, an experienced supplier of wedding dresses and women’s ... bridesmaid dresses for 2014 to its product ... offer to celebrate the coming autumn. All clients can ... off. , The company’s sales representative says, “We ... dresses for consumers from every part of the world. ...
(Date:9/2/2014)... September 02, 2014 Becker's Healthcare ... Center Educational Program on October 23-25, 2014 at ... Annual Meeting - The Business and Operations of ... through high-quality continuing education, networking events, and an ... technologies. , Outstanding educational offerings throughout the three-day ...
(Date:9/2/2014)... Recently, BambooIndustry.com, an excellent company in the ... strand woven bamboo floors to celebrate the coming ... appreciation to the frequent callers, BambooIndustry.com launched a promotion ... to strand woven floors, BambooIndustry.com provides many kinds of ... click strand woven floors, click lock floors, wide plank ...
Breaking Medicine News(10 mins):Health News:Event Gathers World-Renowned Researchers and Community Leaders to Find a Cure for Rare Disease, Friedreich’s Ataxia 2Health News:Event Gathers World-Renowned Researchers and Community Leaders to Find a Cure for Rare Disease, Friedreich’s Ataxia 3Health News:Creatine Monohydrate Reviews Site TopCreatineMonohydrate.com Announces its Launch 2Health News:Elegant Bridesmaid Dresses For 2014, Latest Designs From UWDress.com 2Health News:Becker's Healthcare Announces Ambulatory Surgery Center Educational Program 2Health News:Becker's Healthcare Announces Ambulatory Surgery Center Educational Program 3Health News:Cheap Strand Woven Bamboo Floors For Autumn On Sale At BambooIndustry.com 2
... CIA Interrogation Tactics Confirms Severe and Long-Lasting Harm of Techniques ... ... 17, 2009 -- The newly released Bush Administration,s Office of ... involvement of health professionals in designing, supervising and implementing the ...
... Trauma Center and Neurological Intensive Care UnitATLANTA, April 17 ... gift to Grady Health System to improve emergency care ... The gift will enable Grady to expand hospital ... time-dependent therapies for stroke and acute neurological emergencies. ...
... SINGAPORE, April 17 /PRNewswire-Asia/ -- GfK Asia is pleased ... for the optical,industry today in line with the 14th ... to our recent survey in Malaysia, 25% of,consumers visit ... close to the,Asian average of 28%. "Despite the current ...
... cancer are well known, the risks they confer are ... access journal BMC Medicine describes the exact ... of colorectal cancer in a large group of patients. ... from the Universities of Bristol and Birmingham who studied ...
... Aurora Health Care ... replacement this morning. This first, in Wisconsin, ... reach thousands of viewers. (Photo: http://www.newscom.com/cgi-bin/prnh/20090416/CG00542 ... Aurora caregivers posted updates as "tweets" and answered ...
... SAN DIEGO, Calif., April 16 Join San Diego ... across the country, in making future healthcare decisions known ... Decisions Day is April 16. Now is a great ... directive, because... YOUR DECISIONS MATTER. What is ...
Cached Medicine News:Health News:OLC Memos Confirm Integral Role of Health Professionals in US Torture 2Health News:OLC Memos Confirm Integral Role of Health Professionals in US Torture 3Health News:The Marcus Foundation Gives $20 Million to Grady Health System 2Health News:The Marcus Foundation Gives $20 Million to Grady Health System 3Health News:GfK Asia Releases First Ever Malaysian Contact Lens Industry Retail Measurement 2Health News:GfK Asia Releases First Ever Malaysian Contact Lens Industry Retail Measurement 3Health News:Colorectal cancer risks quantified 2Health News:Aurora Health Care Twitter-Surgery A Success 2Health News:Your Decisions Matter: San Diego Hospice Encourages You to Make Your Healthcare Decisions Known 2
... Chrome-plated metal frames ... ensures optimal cleanliness and ... stools come with user-friendly ... height adjustment. Fixed footring ...
... The ideal modular cleanroom for ... applications that require cleanliness (to Class ... are precision-joined to create ultra-smooth surfaces ... and disinfect. One-inch radius corners simplify ...
... cleanroom for biological safety labs (BSL) ... (to Class 10/ISO 3) and easy ... ultra-smooth surfaces that are easy to ... corners simplify cleaning. Unique double-wall panel ...
Inquire...
Medicine Products: